Cigna GLP-1 Coverage Guide
What GLP-1 Does Cigna Cover in 2026?
By The RX Index Editorial Team — independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters — clinical legitimacy, care quality, transparency, access, and cost — then help you decide where to start.
Published: · Last reviewed:
This page is informational, not medical or insurance advice. Your real coverage is set by your plan documents, formulary, diagnosis, and prior-authorization result. Some links may be affiliate links, but coverage facts and medical accuracy always come first.

Short answer: what GLP-1 does Cigna cover comes down to why it's prescribed. For type 2 diabetes, Cigna's diabetes policy covers GLP-1s like Ozempic, Mounjaro, and Rybelsus (plus Trulicity, Victoza/liraglutide, and other diabetes GLP-1 products). For weight loss, Cigna's separate weight-loss policy covers Wegovy (injection and tablet), Wegovy HD, Zepbound, Foundayo, and Saxenda — but only if your plan includes the benefit, lists the drug, and approves the prior authorization.
The question has a real answer. It's just sorted into coverage lanes — diabetes, weight loss, heart-risk, sleep apnea, and liver disease — and the lane you fall into changes everything. Below, we map every drug to its lane, show the exact proof Cigna wants to approve it, and give you a free way to check your specific plan in a few minutes.
One heads-up first: yes, Cigna confirmed it will cut weight-loss GLP-1 coverage. But only for its own employees, starting July 1, 2026 — not the plan you probably have, and not for diabetes. Here's what that actually means for you.
Cigna GLP-1 coverage at a glance
| If you want a GLP-1 for… | Drugs to check first | What matters most |
|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro, Rybelsus (also Trulicity, Victoza/liraglutide) | Your diagnosis + prior authorization |
| Weight loss / obesity | Wegovy, Zepbound, Foundayo, Saxenda | Whether your plan covers weight-loss drugs + your BMI |
| Sleep apnea (with obesity) | Zepbound | A sleep study showing moderate-to-severe OSA |
| Heart-risk reduction (with overweight/obesity) | Wegovy | Documented heart disease |
| Liver disease (MASH/NASH) | Wegovy | Documented liver fibrosis (stage F2-F3) |
| Not sure yet | Start with the 5-minute myCigna check below | Find your lane before you pay anyone |
What we actually verified for this page
- Cigna's weight-loss GLP-1 coverage policy — reviewed June 17, 2026; policy last revised 04/15/2026.
- Cigna's diabetes GLP-1 coverage policy — reviewed June 17, 2026.
- Cigna's member drug-list guidance (coverage varies by plan) — reviewed June 17, 2026.
- The June 2026 report that Cigna will end weight-loss GLP-1 coverage for its own employees — confirmed against Reuters, U.S. News, CNBC, and Seeking Alpha.
- The May 2025 $200/month copay-cap program from Cigna's Evernorth — confirmed against Reuters, CNBC, and Healthcare Dive.
- Ro's free coverage checker, concierge, formulary, and pricing — reviewed June 17, 2026.
- Plan-specific items we can't confirm generically (your tier, your copay, whether your employer covers weight-loss drugs) are flagged throughout.
What GLP-1 does Cigna cover? The 2026 Cigna coverage matrix
Cigna doesn't approve "GLP-1s" as one category. It runs each drug through a specific coverage lane tied to your diagnosis. The table below maps every GLP-1 to its lane, shows the proof Cigna reviews, the most common reason people get denied, and your best next move.
| Your situation | GLP-1s to check first | Cigna coverage lane | What Cigna generally reviews | Biggest denial risk | Best next step |
|---|---|---|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro, Rybelsus (also Trulicity, Victoza/liraglutide, other exenatide products) | Diabetes GLP-1 policy | Type 2 diabetes diagnosis and the drug's age criteria; some plans add step therapy or extra documentation | Script is for weight loss only, with no diabetes diagnosis | Confirm the drug in myCigna; have your prescriber document the diabetes diagnosis and med history |
| Weight loss / obesity | Wegovy (injection + tablet), Wegovy HD, Zepbound, Foundayo, Saxenda | Weight-loss GLP-1 policy | Plan must include the benefit; BMI ≥30 (or ≥27 with a weight-related condition); ~3 months of diet/lifestyle effort | Employer plan excludes weight-loss drugs, or the PA is missing BMI/lifestyle proof | Check for a weight-loss exclusion first; then build the PA file before the script is sent |
| Heart-risk reduction (with overweight/obesity) | Wegovy (injection + tablet) | Wegovy cardiovascular lane | Adult, BMI ≥27, established heart disease (prior heart attack, prior stroke, or symptomatic peripheral artery disease) | No documented heart disease | Ask your prescriber whether the heart-risk indication applies to you |
| Liver disease (MASH/NASH) | Wegovy (injection + tablet) | MASH/NASH lane | Adult, no cirrhosis, stage F2-F3 liver fibrosis on record, specialist involvement | No fibrosis documentation | Gather liver-stage records before the PA goes in |
| Obstructive sleep apnea (with obesity) | Zepbound | OSA lane | Adult, BMI ≥30, sleep study showing moderate-to-severe OSA (AHI ≥15) | No sleep study / no AHI on record | Use the sleep-apnea route if OSA is your strongest documented condition |
| Ozempic or Mounjaro for weight loss only | Usually the wrong lane | Diabetes policy | These are covered for type 2 diabetes -- not for weight loss without it | Off-label weight-loss request gets denied | Ask whether Wegovy, Zepbound, or Foundayo fits instead |
| You're on the Cigna Group employee health plan | Wegovy/Zepbound become cash-pay for weight loss after June 30, 2026 | Cigna's own employee plan (changes July 1, 2026) | Diabetes coverage continues; weight-loss GLP-1 coverage ends | Assuming this applies to all Cigna plans (it doesn't) | Confirm whether you're on the Cigna Group employee plan or a separate employer plan |
Tier and whether a drug is included vary by your specific Cigna/employer plan, and your plan document supersedes the general policy. Confirm on your plan's drug list.
Sources for this matrix: Cigna's weight-loss GLP-1 coverage policy lists Foundayo, Saxenda (liraglutide), Wegovy (injection and tablet), Wegovy HD, and Zepbound, and recommends prior authorization for each. Cigna's diabetes GLP-1 policy separately governs Ozempic, Mounjaro, Rybelsus, Trulicity, Victoza/liraglutide, and other exenatide products for type 2 diabetes. Wegovy carries separate Cigna lanes for heart-risk reduction and MASH/NASH; Zepbound carries a separate lane for obstructive sleep apnea.
Do this 5-minute check first -- it's free
Before you pay any provider, check your own plan. Log in to myCigna, open Prescriptions → Price a Medication, search the exact drug and form (like "Wegovy injection" or "Ozempic"), and screenshot whether it says covered, PA required, not covered, or excluded. That one screenshot tells you which lane you're in.
No myCigna login handy? You can also have Ro's free checker contact your insurer for you.
Check My GLP-1 Coverage -- Free Report → (sponsored affiliate link, opens in a new tab)Ro contacts your insurer and emails you a written coverage report. New accounts get a $50 credit.
"I heard Cigna is dropping GLP-1 coverage." Are you affected?
Almost certainly not -- unless you work for Cigna. In June 2026, Cigna confirmed it will stop covering GLP-1 weight-loss drugs (Wegovy and Zepbound) in its own employee health plan starting July 1, 2026. A Cigna spokesperson was clear that this change does not affect plans outside its employee plan, and does not affect coverage of GLP-1s for type 2 diabetes.
Let's separate the two things people are mixing up:
- Cigna's employee plan is the health coverage Cigna gives its own staff (~67,700 employees at the end of 2025, mostly U.S.-based). That's the plan cutting weight-loss GLP-1s. Affected employees can refill through June 30, 2026. Cigna pointed them toward cash-pay options through manufacturer sites or TrumpRx. Diabetes coverage continues.
- A Cigna-administered employer plan is what most readers have -- coverage your employer bought and customized, with Cigna as the administrator. Cigna explicitly said the employee-plan change doesn't touch these.
Which GLP-1 medications does Cigna cover for weight loss?
For weight loss, Cigna's policy covers Wegovy (injection, tablet, and HD), Zepbound, Foundayo, and Saxenda -- but only if your plan includes a weight-loss drug benefit and you meet the prior-authorization criteria. A Cigna card alone doesn't guarantee any of these.
Two terms defined once:
- Formulary = your plan's list of covered drugs, sorted into tiers (lower tier = lower cost to you).
- Prior authorization (PA) = approval your doctor has to get before the plan will pay. Think of it as a paperwork gate, not a yes/no button.
Here's the one thing that trips everyone up
Your employer decides whether weight-loss drugs are covered at all. A drug can sit right there on Cigna's policy and still be a flat "no" on your plan -- because your company chose not to include weight-loss medication coverage. This is the single most common reason a perfectly documented prior authorization fails for weight loss. Knowing it today saves you from booking a telehealth visit, waiting three weeks, and only then learning the real blocker was the benefit design -- not your BMI, not your doctor, not your paperwork.
What Cigna wants to see for weight-loss approval
If your plan does cover weight-loss drugs, here's the proof Cigna's policy generally looks for in adults:
| Requirement | What to have ready |
|---|---|
| Age | Adult (generally 18+) |
| BMI | Baseline BMI of 30 or higher, OR 27 or higher with at least one weight-related condition |
| Weight-related condition (if BMI 27-29.9) | High blood pressure, type 2 diabetes, high cholesterol, sleep apnea, heart disease, and similar |
| Lifestyle effort | Documentation of about 3 months of diet and behavior change |
| Ongoing plan | The drug is used alongside a reduced-calorie diet and activity |
| Renewal | Continued coverage usually requires documented weight loss from your starting point |
These thresholds come from Cigna's weight-loss GLP-1 policy. Your specific plan can add steps -- like step therapy (trying a lower-cost drug first) or enrolling in a coaching program (Cigna's Express Scripts unit runs one called EncircleRx on some employer plans).
Verified policy details: Weight Loss - GLP-1 Agonists Prior Authorization. Last revised: 04/15/2026. Initial approval: generally 8 months. Renewal: generally 1 year, with documented weight loss from baseline.
Check your Cigna coverage before you book a visit
Ro runs a free GLP-1 Insurance Coverage Checker that contacts your insurance for you and emails back a written report -- including whether your plan covers Wegovy, Zepbound, or Ozempic, and whether prior authorization is required. No prescription needed, and new accounts get a $50 credit.
Check My GLP-1 Coverage -- Free Report → (sponsored affiliate link, opens in a new tab)Run the free check, then come back and finish the page -- you'll read the rest with your actual coverage in hand.
Does Cigna cover Wegovy?
Yes -- Cigna's weight-loss policy covers Wegovy injection, Wegovy HD, and the newer Wegovy tablet, all with prior authorization, and Wegovy also has separate coverage lanes for heart-risk reduction and liver disease. Which path is strongest depends on why you're taking it. If you have heart disease or documented liver fibrosis, that can open a door that plain weight-loss coverage doesn't.
Wegovy for weight loss
The standard lane. Your plan must include the weight-loss benefit, prior authorization is required, and you'll be measured against the BMI and lifestyle criteria in the table above.
Wegovy for heart-risk reduction
Cigna's policy includes a separate Wegovy lane for reducing major heart events (heart attack, stroke) in adults with established heart disease who are overweight or have obesity. Your records generally need to show real cardiovascular disease -- a prior heart attack, prior stroke, or symptomatic peripheral artery disease -- plus your existing heart treatment and lifestyle plan. This matters because it's tied to a clear medical need, not just weight, so it can be covered on some plans that won't pay for weight loss alone.
Wegovy for liver disease (MASH/NASH)
Cigna also has a lane for MASH (a serious fatty-liver disease, also called NASH) with moderate-to-advanced liver scarring (stage F2-F3 fibrosis). This requires liver-stage documentation and specialist involvement. It's a completely different request than "Wegovy for weight loss."
Wegovy pen vs. Wegovy tablet vs. Wegovy HD
| Form | Why it matters |
|---|---|
| Wegovy pen (injection) | The established weekly injection |
| Wegovy tablet (oral) | Newer pill version -- confirm it's on your plan's formulary, since newer forms aren't always added right away |
| Wegovy HD (higher-dose injection) | A specific lane for people who tolerate the standard dose and need more -- verify the exact form and dose in myCigna |
If Wegovy is the one you want, confirm it's on your plan and whether a prior authorization applies before you start. The free coverage check above does exactly that, in writing. For a deeper look at the prior-auth process, see our Cigna Wegovy prior authorization guide.
Does Cigna cover Zepbound?
Yes -- Cigna's weight-loss policy covers Zepbound for weight loss with prior authorization, and it has a separate lane for obstructive sleep apnea (OSA) in adults with obesity. If you have sleep apnea, that route can be your strongest path, because it's backed by a sleep study instead of weight criteria alone.
Zepbound for weight loss
Same playbook as Wegovy: your plan must include the weight-loss benefit, prior authorization is required, and you're measured against the BMI and lifestyle criteria. Continuation requires documented progress.
Zepbound for obstructive sleep apnea
Cigna's policy covers Zepbound for moderate-to-severe OSA in adults with obesity. The proof Cigna generally wants: age 18+, baseline BMI of 30 or higher, and a sleep study showing OSA with an apnea-hypopnea index (AHI) of 15 or more -- AHI is simply the number of breathing interruptions per hour of sleep. If sleep apnea is your reality, this is a real, defensible lane.
Zepbound vs. Mounjaro on Cigna -- a key point
They're the same active drug (tirzepatide), but they live in different coverage lanes:
- Zepbound = the weight-loss / sleep-apnea brand → weight-loss policy.
- Mounjaro = the type 2 diabetes brand → diabetes policy.
Same molecule does not mean same coverage route. If your goal is weight loss, Zepbound is the brand to check -- not Mounjaro. For more on the PA process, see our Cigna Zepbound prior authorization guide.
Does Cigna cover Ozempic or Mounjaro?
Yes -- for type 2 diabetes. Cigna's diabetes policy covers Ozempic and Mounjaro with prior authorization for people with type 2 diabetes, but it does not cover them for weight loss alone without a diabetes diagnosis. If your goal is weight loss, the Cigna-approved path is a weight-loss drug (Wegovy, Zepbound, Foundayo, or Saxenda), subject to your plan and PA rules.
Ozempic coverage lane
Covered for type 2 diabetes. Expect the request to document the diagnosis and meet the drug's age criteria; your plan may add step therapy or other requirements. An off-label weight-loss request -- "I want Ozempic to lose weight but I don't have diabetes" -- is a common denial. For details, see our guide on whether Cigna covers Ozempic.
Mounjaro coverage lane
Covered for type 2 diabetes. For weight loss, Zepbound (not Mounjaro) is the tirzepatide brand to check -- same molecule, different coverage lane. For the Zepbound weight-loss route, see our Cigna Zepbound coverage guide.
What if you have prediabetes, PCOS, or insulin resistance -- but not full diabetes?
This is a real gray zone. Don't try to force Ozempic or Mounjaro through the diabetes lane if you don't qualify. We cover the related routes in our guide on GLP-1 coverage for prediabetes.
The rule we won't bend
Never ask a doctor to code a diagnosis you don't have. That's insurance fraud, and it can blow up on you. The right move isn't gaming the lane -- it's matching the correct medication and documentation to the indication you genuinely meet. If you don't fit the diabetes lane, the answer is a weight-loss-indicated drug, an appeal, or a cash-pay path -- not a fake diagnosis.
Verified Cigna policy details -- diabetes lane: Policy reviewed: Diabetes -- GLP-1 Agonists Prior Authorization. Reviewed: June 17, 2026. Lane: type 2 diabetes. Note: the diabetes-policy drugs are not considered medically necessary for weight loss without type 2 diabetes.
Does Cigna cover GLP-1 pills?
Some, yes -- but the reason for use still decides the lane. For weight loss, Cigna's weight-loss policy covers the Wegovy tablet and Foundayo (orforglipron) when your plan and PA criteria are met. For diabetes, Rybelsus (oral semaglutide) sits in the diabetes lane.
- Wegovy tablet -- weight-loss lane; verify it's on your formulary (newer forms can lag).
- Foundayo (orforglipron) -- a newer oral GLP-1 for weight management, listed in Cigna's weight-loss policy; check your plan and tier in myCigna.
- Rybelsus -- diabetes lane, not a weight-loss shortcut.
What is Cigna's GLP-1 prior authorization checklist?
The biggest mistake people make is treating prior authorization like a yes/no request instead of a documentation package. For weight-loss GLP-1s, your file should support the plan benefit, your BMI, a weight-related condition (if your BMI is 27-29.9), about 3 months of lifestyle effort, and your ongoing plan. For diabetes GLP-1s, it should clearly establish type 2 diabetes. Strong files get approved faster; thin files get denied.
What to gather, by lane
| Coverage lane | Documents to have ready |
|---|---|
| Type 2 diabetes | Diagnosis, recent labs, medication history, current treatment plan |
| Weight loss | Baseline BMI, current weight, ~3 months of diet/behavior records, a weight-related condition (if BMI 27-29.9), reduced-calorie/activity plan |
| Sleep apnea | Sleep study, AHI, OSA diagnosis, BMI, treatment history |
| Heart-risk | Records of prior heart attack/stroke/peripheral artery disease, BMI, current heart treatment |
| Liver disease (MASH/NASH) | Fibrosis stage (F2-F3), the test it came from, specialist involvement |
Five questions to ask your prescriber
- "Which diagnosis are we submitting under?"
- "Does my chart show the baseline BMI Cigna wants?"
- "Do we have the lifestyle documentation Cigna may require?"
- "If this is Ozempic or Mounjaro, are we submitting for type 2 diabetes?"
- "Who follows up if Cigna asks for more information?"
Five questions to ask Cigna (or Express Scripts)
- "Is this drug on my plan's formulary, and what tier?"
- "Is prior authorization required?"
- "Are weight-loss medications excluded on my plan?"
- "Is there step therapy?"
- "What's my expected cost after my deductible?"
Let someone handle the paperwork for you
If chasing paperwork sounds exhausting, Ro's insurance concierge can help you navigate the coverage process -- including submitting prior-authorization requests and finding your estimated copay for FDA-approved GLP-1s. Your Ro Body membership is $39 the first month, then $149/month -- or as low as $74/month with an annual plan paid upfront (medication is billed separately at your copay if covered).
See How Ro Handles My Prior Authorization → (sponsored affiliate link, opens in a new tab)GLP-1 medications are prescription drugs and aren't right for everyone. Talk with a licensed clinician about your personal risks before starting, stopping, or switching any GLP-1.
How do you check your own Cigna GLP-1 coverage?
The only answer that's truly yours lives inside your own Cigna account, not a generic article. The fastest reliable check takes about five minutes.
Step-by-step: the myCigna check
- Log in to myCigna.
- Go to Prescriptions / Pharmacy.
- Open "Price a Medication" (or "See prescription drug list").
- Search the exact drug name and form (e.g., "Wegovy injection," "Zepbound," "Ozempic").
- Read what it says: covered, PA required, not covered, excluded, non-preferred, or alternatives available.
- Screenshot the result before you pay for any visit.
- If it's unclear, call Cigna and ask whether the issue is the formulary, your diagnosis, a benefit exclusion, or a missing PA.
What each result actually means
| What myCigna says | What it usually means | What to do |
|---|---|---|
| Covered | Your plan may pay, after cost-sharing | Confirm your copay/deductible |
| PA required | Coverage is possible, but paperwork is needed | Build your PA file (above) |
| Not covered | The drug isn't on your formulary, or the indication doesn't match | Ask about covered alternatives |
| Excluded | A benefit-design block -- usually employer-driven | Ask HR/benefits; consider cash-pay |
| Non-preferred | Covered, but costly or behind step therapy | Ask about a preferred alternative |
| Unknown / can't determine | The portal can't tell | Call Cigna, or have Ro's free checker contact them for you |
This decoder is the difference between "ugh, denied, I give up" and "okay, this is a benefit exclusion, so paperwork won't fix it -- time for plan B." Different results call for completely different moves.
What if Cigna denies your GLP-1?
A denial isn't one problem -- it's several, and the fix depends on which one you got. Some denials (missing paperwork, wrong diagnosis lane, step therapy) are very fixable. Others (a flat weight-loss exclusion) usually require a different covered indication, an employer benefit change, or a cash-pay path. The first step is always the same: find out exactly why.
Denial decoder
| Denial reason | What it means | Best move |
|---|---|---|
| PA not submitted | The pharmacy hit a gate; the insurer needs paperwork | Ask your prescriber to submit the PA |
| Missing documentation | The PA was incomplete | Add BMI, diagnosis, condition, lifestyle proof, labs |
| Wrong indication | The drug doesn't match the reason given | Ask whether a different GLP-1 lane fits |
| Weight-loss exclusion | Your plan doesn't cover anti-obesity drugs | Ask HR/benefits; consider cash-pay |
| Continuation failure | Renewal criteria weren't met | Ask exactly which metric was missing |
| Non-formulary | The drug isn't on your plan's list | Ask about covered alternatives |
| Step therapy | The plan wants another treatment tried first | Ask what must be tried and documented |
A line to use when you call
"I'm trying to understand whether this denial was a plan exclusion, missing prior-authorization documentation, a diagnosis mismatch, step therapy, or formulary status. Please tell me the exact denial reason and the documentation needed for reconsideration."
A first "no" often isn't the final answer
If your denial came from missing documentation, the wrong indication, step therapy, or a PA processing issue, it can frequently be fixed -- get the exact reason in writing and resubmit with what's missing. The one denial that paperwork usually can't fix is a plan exclusion: if your employer simply doesn't cover weight-loss drugs, more documents won't change it.
When to stop fighting and switch paths
Move on from the insurance fight if:
- Your plan excludes weight-loss drugs entirely (paperwork can't fix a benefit design).
- You don't have the diagnosis a diabetes drug requires.
- Your documentation simply doesn't match the indication.
- The delay is causing repeated missed fills and your clinician agrees another route makes sense.

If Cigna won't cover it, compare FDA-approved cash-pay options
If your plan excludes weight-loss drugs, you're not stuck. Ro offers FDA-approved GLP-1s at cash prices matched to the manufacturers (LillyDirect, NovoCare, and TrumpRx) -- the Wegovy pill starts around $149/month at the lowest dose.
See FDA-Approved Cash-Pay Prices → (sponsored affiliate link, opens in a new tab)Cash offers generally can't be combined with insurance. Verify current pricing on Ro's site.
Which online GLP-1 path makes sense if you have Cigna?
If you have Cigna and want insurance to pay when possible, start with an FDA-approved coverage check -- not a cash-pay compounded program. For this exact situation, we point readers to Ro first, because it's built for insurance-and-brand-name needs: a free coverage check, a concierge that handles the prior-auth paperwork, and a real FDA-approved menu.
Best first step if you want Cigna to pay: Ro
We recommend Ro here for one honest reason: when your question is "will my plan pay, and how do I make that happen," Ro does the two things that actually move the needle. It runs a free check that contacts your insurer and emails you a written coverage report (with a $50 credit for new accounts), and its insurance concierge submits the prior-authorization paperwork. Ro carries FDA-approved GLP-1s including the Wegovy pill, Wegovy pen, Zepbound pen, Zepbound KwikPen, and Foundayo, at cash prices matched to LillyDirect, NovoCare, and TrumpRx.
To be clear about what Ro is and isn't: Ro can't promise Cigna will cover your drug -- no provider can, because that's your plan's call, not theirs. Treat it as a coverage-check and prior-auth support path.
Provider claims vs. what we verified
| Claim | What we verified | Source | The catch |
|---|---|---|---|
| Ro's coverage checker is free | Ro contacts your insurer and emails a personalized coverage report at no charge | Ro coverage-checker page | The report tells you your coverage; the outcome still depends on your plan |
| $50 credit | New Ro accounts receive a $50 credit | Ro coverage-checker page | New accounts only |
| Ro Body pricing | $39 first month, then $149/month, as low as $74/month on an annual plan | Ro pricing page | Membership is separate from medication; verify current pricing |
| Manufacturer-matched cash pricing | FDA-approved GLP-1s at prices matching LillyDirect/NovoCare/TrumpRx; Wegovy pill from ~$149/month at the starting dose | Ro pricing page | Prices vary by drug and dose; some are limited-time |
| $200/month cap on Wegovy/Zepbound | Cigna's Evernorth caps out-of-pocket at $200/month, counting toward the deductible, with up to ~$3,600/year in savings | Reuters / Evernorth | Only on employer plans that opt in |
| Costco cash pricing | Costco's member program lists cash prices on Wegovy and Ozempic | Costco member program page | Cash offers generally don't combine with insurance |
Start the coverage check with Ro
Free, medication-specific, and emailed to you -- find out whether your Cigna plan lists Ozempic, Wegovy, or Zepbound and whether prior authorization applies, before you commit to anything.
Check My Cigna GLP-1 Coverage With Ro → (sponsored affiliate link, opens in a new tab)When NOT to use a provider link
If you're still figuring things out, don't click a provider yet. Skip straight to our quiz if you're:
- Just checking whether your plan excludes weight-loss drugs
- Trying to understand a denial
- Unsure whether your situation is diabetes or weight management
- Not sure whether you need Wegovy, Zepbound, Ozempic, Mounjaro, or a pill
For those situations, take the free 60-second matching quiz. And if you'd rather have a person walk your insurance with you, see our guide to GLP-1 providers that work with Cigna.
How much does a Cigna-covered GLP-1 actually cost?
There's no single Cigna GLP-1 price. With coverage, you typically pay a copay rather than the full sticker price -- in Ro's 2025 coverage-checker data, half of covered patients paid $50/month or less. Without weight-loss coverage, branded GLP-1s have list prices over $1,000/month, though FDA-approved cash-pay options start far lower. Your exact number depends on your plan, your deductible, and your prior-authorization result.
Why two Cigna members pay completely different prices
- Different employer benefits
- Different formularies and tiers
- Different deductibles
- Different prior-authorization outcomes
- Different diagnoses (diabetes vs. weight loss)
- Different pharmacy networks
In Ro's own coverage-checker data, 43% of users had weight-loss GLP-1 coverage, and nearly all had diabetes GLP-1 coverage. Coverage is more common than people fear -- but the spread is huge.
The $200 cap, explained honestly
In May 2025, Cigna's Evernorth unit launched an add-on that caps out-of-pocket costs at $200/month for Wegovy and Zepbound, with that amount counting toward your deductible. It can save up to about $3,600/year versus buying direct. Two important caveats: it's only on employer plans that opt in (ask HR whether yours did), and at the time of the announcement, only about half of Cigna's clients covered these drugs at all. The cap is real and helpful -- but it isn't a universal Cigna price.
Cash-pay comparison if you're not covered
| Path | Best for | The catch |
|---|---|---|
| Ro | Insurance check + FDA-approved options in one place | Membership fee on top of medication |
| Sesame / Costco | Provider choice + pharmacy cash pricing | Cash offers may be time-limited and won't stack with insurance |
| LillyDirect / NovoCare (manufacturer) | You already have a prescription | No care navigation included |
| The RX Index quiz | You're not sure which path fits | Not a prescription service |
What changed for Cigna GLP-1 coverage recently?
Cigna GLP-1 coverage is moving fast, so old answers go stale quickly. Three things changed the picture in 2025-2026: newer drugs and forms entered the policy, Cigna added a $200 copay-cap program for some employers, and Cigna will cut weight-loss GLP-1 coverage for its own employees. None of these is a blanket "Cigna covers / doesn't cover GLP-1s" -- they're moving pieces, which is exactly why you check your own plan.
- Newer drugs/forms to verify on your plan: Wegovy tablet, Wegovy HD, Foundayo, plus the Zepbound sleep-apnea lane and the Wegovy liver-disease lane.
- The $200 cap (May 2025) -- an opt-in employer add-on for Wegovy/Zepbound.
- Cigna's employee-plan cut (effective July 1, 2026) -- its own staff only; doesn't affect other plans or diabetes coverage.
Because of all this churn, we re-verify this page on a set schedule and keep a visible "last verified" date at the top.
What should you do next if you have Cigna and want a GLP-1?
Your next step depends on what myCigna told you. Don't pay for a program until you know whether your blocker is coverage, prior authorization, a diagnosis mismatch, or a benefit exclusion.
- If myCigna says "covered": confirm prior authorization, confirm your copay, and have your prescriber submit the right diagnosis and documentation. Want help? Ro's concierge can manage the PA (sponsored affiliate link, opens in a new tab).
- If myCigna says "PA required": use the checklist above, gather your documents, and confirm who follows up. Or have Ro's checker confirm the requirement first (sponsored affiliate link, opens in a new tab).
- If myCigna says "not covered" or "excluded": ask whether it's a formulary issue or a benefit exclusion, ask if another indication applies, then compare FDA-approved cash-pay paths (sponsored affiliate link, opens in a new tab).
- If you don't know which drug fits: take the quiz and bring the result to a clinician -- don't self-select on price alone.
Cigna GLP-1 coverage: real questions, straight answers
- What GLP-1 does Cigna cover?
- Cigna covers different GLP-1s depending on your diagnosis and plan. For type 2 diabetes, its diabetes policy covers Ozempic, Mounjaro, Rybelsus, Trulicity, Victoza/liraglutide, and other exenatide products. For weight loss, its policy covers Wegovy (injection and tablet), Wegovy HD, Zepbound, Foundayo, and Saxenda -- but only if your plan includes the weight-loss benefit and you meet the prior-authorization criteria. Compounded semaglutide is not covered.
- Does Cigna cover Wegovy?
- Yes. Cigna's weight-loss policy covers Wegovy injection, Wegovy HD, and the Wegovy tablet with prior authorization, as long as your plan includes the weight-loss benefit. Wegovy also has separate Cigna lanes for heart-risk reduction and liver disease (MASH/NASH).
- Does Cigna cover Zepbound?
- Yes. Cigna covers Zepbound for weight loss with prior authorization (this depends on your plan), and it has a separate lane for obstructive sleep apnea in adults with obesity, which requires a sleep study showing moderate-to-severe OSA (AHI of 15 or more).
- Does Cigna cover Ozempic for weight loss?
- Generally no. Cigna covers Ozempic for type 2 diabetes, but its diabetes policy does not cover it for weight loss without a diabetes diagnosis. For weight loss, the Cigna-approved options are Wegovy, Zepbound, Foundayo, or Saxenda.
- Does Cigna cover Mounjaro for weight loss?
- Mounjaro is covered for type 2 diabetes. For weight loss, Zepbound is the tirzepatide brand to check under Cigna's weight-loss policy -- same active drug, different coverage lane.
- Does Cigna cover GLP-1 pills?
- Some. For weight loss, the Wegovy tablet and Foundayo are in Cigna's weight-loss policy. For diabetes, Rybelsus is in the diabetes policy. The reason for use and your plan's formulary decide the path. Compounded oral products are not covered.
- Does Cigna require prior authorization for GLP-1s?
- Yes. Cigna's diabetes and weight-loss GLP-1 policies both call for prior authorization on the GLP-1 drugs they cover.
- What BMI does Cigna require for Wegovy or Zepbound?
- For adult weight-loss coverage, Cigna's policy generally references a baseline BMI of 30 or higher, or 27 or higher with at least one weight-related condition, plus other requirements such as documented lifestyle effort.
- What if my employer excludes weight-loss medications?
- Then prior authorization won't solve it. Confirm with Cigna or HR whether it's a benefit exclusion, ask whether a different covered diagnosis applies (like heart-risk or sleep apnea), and compare FDA-approved cash-pay options.
- Did Cigna stop covering GLP-1s?
- Cigna will stop covering weight-loss GLP-1s in its own employee plan, effective July 1, 2026. That change does not affect other Cigna-administered plans, and it does not affect coverage of GLP-1s for type 2 diabetes.
- Can Ro make Cigna cover my GLP-1?
- No provider can guarantee coverage. Ro can run a free coverage check and help with prior authorization, but the outcome depends on your plan, diagnosis, formulary, and documentation.
Still not sure which GLP-1 program is right for you?
Answer a few questions about your insurance, diagnosis, budget, and preferred medication route. We'll show you the most realistic next step -- coverage check, prior-auth prep, FDA-approved cash-pay, or another path.
Start the Free 60-Second Quiz →How we made this page (and who made it)
By The RX Index Editorial Team. The RX Index is independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters -- clinical legitimacy, care quality, transparency, access, and cost -- then help you decide where to start.
How we built it: We read Cigna Healthcare's current GLP-1 prior-authorization policies (diabetes and weight-loss), Cigna's member drug-list guidance, the FDA-approved indications referenced in those policies, and the providers' own pages. We confirmed the June 2026 employee-plan change and the May 2025 $200 copay-cap program against multiple independent news outlets. We separated medical and regulatory facts from commercial provider facts, and we flagged anything that depends on your specific plan.
Why this page exists: People searching for what GLP-1 Cigna covers usually aren't shopping -- they're trying to avoid a denial, a wasted appointment, or a surprise bill. This guide exists to help you find your coverage lane before you pay anyone.
This page is not medical advice, insurance advice, or a guarantee of coverage. Your plan documents, formulary, diagnosis, prior authorization, and pharmacy benefit control your actual coverage. The RX Index may earn a commission if you start a program through links on this page; this never affects our coverage classifications, which are based on Cigna's published policy.
Last verified: June 17, 2026 · Next scheduled review: July 2026 · Update triggers: any Cigna policy revision, FDA label change, Ro/Sesame/Costco price change, or major employer benefit announcement.
Sources
- Cigna -- Weight Loss GLP-1 Agonists Prior Authorization Policy (revised 04/15/2026). cigna.com/assets/chcp/pdf/coveragePolicies/cnf/cnf_684_[...].pdf
- Cigna -- Diabetes GLP-1 Agonists Prior Authorization Policy. cigna.com/assets/chcp/pdf/coveragePolicies/cnf/cnf_360_[...].pdf
- Cigna -- Prescription Drug List and Coverage (member guidance). cigna.com/individuals-families/member-guide/offered-by-employers-drug-list
- Reuters via U.S. News -- "Cigna Drops Coverage of GLP-1 Obesity Drugs for Its Own Employees" (June 2, 2026). money.usnews.com/investing/news/[...]
- CNBC -- "Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs" (May 21, 2025). cnbc.com/2025/05/21/cigna-eli-lilly-novo-nordisk-weight-loss-drugs.html
- Healthcare Dive -- "Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays" (May 2025). healthcaredive.com/news/evernorth-glp-copay-cap-wegovy-zepbound/748853/
- Ro -- GLP-1 Insurance Coverage Checker. ro.co/weight-loss/glp1-insurance-checker/
- Ro -- Weight Loss Program Pricing. ro.co/weight-loss/pricing/
- Ro -- 2025 GLP-1 Insurance Coverage Checker Report. ro.co/weight-loss/coverage-checker-report/
- FDA -- Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. fda.gov/drugs/[...]
- Costco -- Member Prescription Program (cash pricing). costco.com/member-prescription-program.html
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 60 seconds · no signup